The Drug Enforcement Administration (DEA) says in a new filing that the marijuana rescheduling process remains stalled at the stage it has been on for months, despite the head of agency’s prior commitment to senators that he would prioritize the issue if confirmed for the role.
President Donald Trump said in August that he intended to make a decision on the proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) within weeks. But more than two months later, the administration has yet to move on the reform.
Amid the inaction, DEA and pro-reform witnesses in the rescheduling case that was previously before an agency administrative law judge have again submitted a joint status report saying there is mutual agreement that an appeal of the proceedings remains pending.
“To date, Movants’ interlocutory appeal to the Administrator regarding their Motion to Reconsider remains pending with the Administrator,” the filing, submitted on Monday, says. “No briefing schedule has been set.”
This doesn’t constitute a new delay of rescheduling’s consideration, which has been stalled out for months after legal challenges to the administrative process were raised during prior proceedings. But it does signal that there hasn’t been
Read full article on Marijuana Moment
